Bezos, Altman and Milner have poured billions into cell reprogramming as the new anti-aging frontier — and Life Biosciences just dosed the first human, but the field’s older bets left few clinical wins and brutal trial misses
Cell reprogramming — the technique of returning adult cells to a more youthful state using four genetic factors identified in ...
